Immunovant, Inc. (NASDAQ:IMVT) Q3 2026 Earnings Call Transcript February 6, 2026 Immunovant, Inc. beats earnings expectations. Reported EPS is $-0.60951, expectations were $-0.72. Operator: Good day, ...
The defence stock rose 6.42% to Rs 2689 today against the previous close of Rs 2526 on BSE. Market cap of the firm climbed to ...
Money pouring into AI infrastructure continues to boost the fortunes of test suppliers. Japanese semiconductor test giant, ...
Both companies are seeing spectacular sales growth due to AI-driven demand for computing capacity.
Indian stock market poised for rebound after sharp fall; Sensex, Nifty 50 open higher amid Gift Nifty rally, India-EU trade ...
Specializing in automation software for enterprises, this tech firm reported a notable insider sale amid ongoing shifts in ...
WWE Royal Rumble 2026: The journey to WrestleMania begins in earnest this weekend with WWE Royal Rumble 2026 going live, ...
With all 36 Champions League teams in action simultaneously, Matchday 8 of the league phase delivered plenty of drama to cap ...
KESKO CORPORATION JANUARY-DECEMBER FINANCIAL STATEMENTS RELEASE 5.2.2026 AT 8.00Financial performance in brief: 10-12/2025 Group net sales in October-December totalled €3,230.9 million (€3,040.6 milli ...
Discusses Backlog, Pipeline, and Revenue Recognition Strategy Across AI Infrastructure and Data Center Programs ...
Get all latest & breaking news on Taro Pharmaceutical Industries. Watch videos, top stories and articles on Taro Pharmaceutical Industries at moneycontrol.com.